Biological Effects of Human Serum Albumin from Different Sources on Vascular Endothelial Cells

doi:10.3969/j.issn.1671-2587.2024.05.001

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2024, Vol. 26 ›› Issue (5): 577-586.DOI: 10.3969/j.issn.1671-2587.2024.05.001

Biological Effects of Human Serum Albumin from Different Sources on Vascular Endothelial Cells

LIU Qing¹, WANG Zongkui¹, XU Jun², CHEN Lu², LI Changqing¹, DU Xi¹, MA Li¹

¹Chinese Academy of Medical Sciences, Peking Union Medical College, Institute of Blood Transfusion, Chengdu 610052;
²Shanghai RAAS Blood Products Co., Ltd, Shanghai 201401

Received:2024-06-26 Online:2024-10-20 Published:2024-09-20

Abstract

Abstract: Objective To evaluate the differential biological effects of human serum albumin (HSA) derived from different sources on vascular endothelial cells. Methods Human umbilical vein endothelial cells (HUVEC) were serum-starved and then exposed to HSA from varied sources. Cellular responses were assessed using the CCK-8 assay for proliferation, Annexin V-FITC kit for apoptosis, and flow cytometry for cell cycle analysis. The proliferative, apoptotic and cell cycle effects of HSA from different sources were statistically compared. Additionally, the impact of HSA on HUVEC cell migration and tube formation was assessed via scratch assays and tube formation experiments. Results Yeast-derived rHSA1 did not affect HUVEC proliferation (P=0.49, q=1.601), while other HSA sources significantly promoted it (P<0.001, F=10.84). All HSA treatment groups exhibited an inhibitory effect on HUVEC apoptosis (P<0.001), with no statistically significant differences in the proportions of live cells (P=0.07, F=2.415), apoptotic cells (P=0.2, F=1.624), and dead cells (P=0.28, F=1.376) across treatment groups. Compared to the serum-free control group, except for the pHSA2 and pHSA6 treatment groups, which showed a significant decrease in G0/G1 phase cell proportion (P<0.001) and a significant increase in G2/M phase cell proportion (P<0.01), the proportions of cells in other cell cycle phases did not show significant changes in the HSA treatment groups. In the scratch assay, in contrast to the serum-free control group, the pHSA(1) and pHSA(2) groups exhibited a higher degree of wound healing at 12 h (P<0.001), 24 h (P<0.001), and 36 h (P<0.001, P=0.002); however, no significant differences were observed in the rHSA(1) and rHSA(2) groups compared to the control group. Likewise, in the tube formation assay, the pHSA(1) and pHSA(2) groups significantly enhanced node formation (P=0.001, P=0.005), tubular branching (P<0.001), and mesh structure development (P<0.001), whereas the rHSA(1) and rHSA(2)groups showed no such enhancements. Conclusion HSA from different sources significantly inhibits endothelial cell apoptosis under serum-free conditions, but exerts varying effects on proliferation, cell cycle regulation, cell migration, and tube formation of vascular endothelial cells.

Key words: Human Serum Albumin, Vascular Endothelial Cells, Proliferation, Apoptosis, Migration, Angiogenesis

CLC Number:

R457.1⁺4Q512⁺.1

LIU Qing, WANG Zongkui, XU Jun, CHEN Lu, LI Changqing, DU Xi, MA Li. Biological Effects of Human Serum Albumin from Different Sources on Vascular Endothelial Cells[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(5): 577-586.

References

[1] GOMEZ-SALINERO J M,RAFII S. Endothelial cell adaptation in regeneration[J]. Science,2018, 362(6419):1116-1117.
[2] DEMIDOVA-RICE T N,DURHAM J T,HERMAN I M. Wound healing angiogenesis:innovations and challenges in acute and chronic wound healing[J]. Adv Wound Care (New Rochelle),2012,1(1):17-22.
[3] PRIES A R,BADIMON L,BUGIARDINI R,et al.Coronary vascular regulation,remodelling,and collateralization:mechanisms and clinical implications on behalf of the working group on coronary pathophysiology and microcirculation[J]. Eur Heart J, 2015,36(45):3134-3146.
[4] HAO D K,XIAO W W,LIU R W,et al.Discovery and characterization of a potent and specific peptide ligand targeting endothelial progenitor cells and endothelial cells for tissue regeneration[J]. ACS Chem Biol,2017, 12(4):1075-1086.
[5] COMMITTEE N P.Chinese Pharmacopoeia [M]. Beijing: China Medical Science and Technology Press, 2020.
[6] 欧阳生珀,童荣生. 人血白蛋白的合理应用概述[J]. 中国医院药学杂志,2021,41(4):425-429.
[7] SERRA R,GRANDE R,BUFFONE G,et al.Albumin administration prevents the onset of pressure ulcers in intensive care unit patients[J]. Int Wound J,2015,12(4): 432-435.
[8] XIANG F,HUANG F H,HUANG J P,et al.Expert consensus on the use of human serum albumin in adult cardiac surgery[J]. Chin Med J,2023,136(10):1135-1143.
[9] 张轶菡,吴延. 人血清白蛋白在心脏手术中的应用[J]. 国际麻醉学与复苏杂志,2023,44(9):985-989.
[10] HARIRI G,JOFFRE J,MAURY E,et al.Ten myths about albumin:do not forget the endothelium[J]. Intensive Care Med,2022,48(8):1097-1098.
[11] MIKKAT S,DOMINIK A,STANGE J,et al.Comparison of accompanying proteins in different therapeutic human serum albumin preparations[J]. Biologicals,2020,64:41-48.
[12] 郭江红,谢育媛,柯兵兵,等. 人血白蛋白质量评价与研究[J]. 中国药学杂志,2019,54(9):734-740.
[13] 窦姿,赵小洁,张齐明,等. 人血白蛋白生产过程中多聚体含量的检测[J]. 中国输血杂志,2021,34(8):909-913.
[14] BAI X,WANG X,XU Q B.Endothelial damage and stem cell repair in atherosclerosis[J]. Vasc Pharmacol, 2010,52(5/6):224-229.
[15] HE L J,HUANG X Z,KANISICAK O,et al.Preexisting endothelial cells mediate cardiac neovascularization after injury[J]. J Clin Invest,2017,127(8):2968-2981.
[16] BLOOM S I,ISLAM M T,LESNIEWSKI L A,et al.Mechanisms and consequences of endothelial cell senescence[J]. Nat Rev Cardiol,2023,20(1):38-51.
[17] WEINBAUM S,TARBELL J M,DAMIANO E R.The structure and function of the endothelial glycocalyx layer[J]. Annu Rev Biomed Eng,2007,9:121-167.
[18] CHAPPELL D,JACOB M,PAUL O,et al.The glycocalyx of the human umbilical vein endothelial cell:an impressive structure ex vivo but not in culture[J]. Circ Res,2009,104(11):1313-1317.
[19] SCHÖTT U,SOLOMON C,FRIES D,et al. The endothelial glycocalyx and its disruption,protection and regeneration:a narrative review[J]. Scand J Trauma Resusc Emerg Med,2016,24:48.
[20] MISHRA V,HEATH R J.Structural and biochemical features of human serum albumin essential for eukaryotic cell culture[J]. Int J Mol Sci,2021,22(16):8411.
[21] 沈夕坤,江国荣,张露蓉. 白蛋白对内皮细胞增殖的影响[J]. 辽宁中医学院学报,2004,6(5):422-423.
[22] LIN W D,LU S L,QING C,et al.Proliferation-inhibiting effect of advanced glycation end products modified human serum albumin to vascular endothelial cell ECV304[J]. Zhonghua Yi Xue Za Zhi,2003,83(7):572-576.
[23] JU C W,SHENG Z L,WANG Q Y,et al.Advanced glycation end products of bovine serum albumin affect the cell growth of human umbilical vein endothelial cells via modulation of MEG3/miR-93/p21 pathway[J]. Acta Biochim Biophys Sin (Shanghai),2019,51(1):41-50.
[24] ZOELLNER H,HÖFLER M,BECKMANN R,et al. Serum albumin is a specific inhibitor of apoptosis in human endothelial cells[J]. J Cell Sci,1996,109( Pt 10): 2571-2580.
[25] BARBARO B,KUECHLE J,SALEHI P,et al.Increased albumin concentration reduces apoptosis and improves functionality of human islets[J]. Artif Cells Blood Substit Immobil Biotechnol,2008,36(1):74-81.
[26] LIU S Y,CHEN C L,YANG T T,et al.Albumin prevents reactive oxygen species-induced mitochondrial damage, autophagy,and apoptosis during serum starvation[J]. Apoptosis,2012,17(11):1156-1169.
[27] KATAYAMA N,NAKAJOU K,ISHIMA Y,et al.Nitrosylated human serum albumin (SNO-HSA) induces apoptosis in tumor cells[J]. Nitric Oxide,2010,22(4): 259-265.
[28] IBRAHIM B,STANGE J,DOMINIK A,et al.Albumin promotes proliferation of G1 arrested serum starved hepatocellular carcinoma cells[J]. PeerJ,2020,8:e8568.
[29] UDDIN S.Cell Cycle Progression Effects of Albumin[M]. 2021.
[30] LAMALICE L,LE BOEUF F,HUOT J.Endothelial cell migration during angiogenesis[J]. Circ Res,2007, 100(6):782-794.
[31] WANG A H,NOMURA M,PATAN S,et al.Inhibition of protein kinase Calpha prevents endothelial cell migration and vascular tube formation in vitro and myocardial neovascularization in vivo[J]. Circ Res
[32] CARLEVARO M F,ALBINI A,RIBATTI D, et al.Transferrin promotes endothelial cell migration and invasion:implication in cartilage neovascularization[J]. 1997,136(6):1375-1384.
[33] GRAY N,LIMBERG M M,BRÄUER A U,et al. Novel functions of S1P in chronic itchy and inflammatory skin diseases[J]. J Eur Acad Dermatol Venereol,2022, 36(3):365-372.
[34] KANO K,AOKI J,HLA T.Lysophospholipid mediators in health and disease[J]. Annu Rev Pathol, 2022,17: 59-483.
[35] QIU Y,SHEN J Y,JIANG W L,et al.Sphingosine 1-phosphate and its regulatory role in vascular endothelial cells[J]. Histol Histopathol,2022,37(3):213-225.

Biological Effects of Human Serum Albumin from Different Sources on Vascular Endothelial Cells

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 14

Recommended Articles

Metrics

Comments

About

Author

Journal

Access Statistics

Contact

[1]	XUE Changwen, SHAO Xiaobao, CHEN Xin, ZHOU Lin, ZHU Peiyuan. Experimental Study on Inhibition of Interaction between Platelets and Tumor Cells by Ginkgolide B [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(2): 205-212.
[2]	LUO Jingling, YANG Lei. Effect of Apheresis Platelets Transfusion on Proliferation and Metastasis of Hepatocellular Carcinoma Cells [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(4): 456-460.
[3]	LIU Ting, WEN Yanping. MiR-532-3p Targets SERPINE1 and Regulates ECM RECEPTOR INTERACTION to Inhibit Proliferation and Migration of Colon Adenocarcinoma Cells [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(3): 324-333.
[4]	WANG Zhi-feng, SUN Hao, HU Dian, et al. LncRNAs ABHD11-AS1 Targets miR-133a to Upregulate EGFR Expression and Promote Ovarian Cancer cell Proliferation [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(5): 574-581.
[5]	YANG Hui-kuan, WU Qian-yu, ZHANG Jia-yi, et al. miRNA May Serve as a Promising Marker for Platelet Lesion during Storage in Blood Bank Condition [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(2): 176-181.
[6]	ZHANG Yi-yu, HUANG Guo-qing, ZHANG Yong-gang, et al. Regulation of Ubiquitin Mediated Proteolytic Pathway: Predictive Analysis of CircRNA Changes in Stored Red Blood Cells [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(4): 420-427.
[7]	ZHANG Yi-yu, HUANG Guo-qing, WANG Qiang, et al. Study on Decreased Expression of CircRNAs in Stored Erythrocytes and Their Target Genes Prediction [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(4): 428-434.
[8]	SHI Lan, XU Liang-fei, NIE Zheng-chao, et al. Study on the Inhibitory Mechanism of Staphylococcus Aureus Leukocidin S Component LukS-PV on the Proliferation in Acute Myeloid Leukemia Cells [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(6): 603-609.
[9]	ZHAO Xing-yun, BIAN Mao-hong. Advances in Research on Relationship between MicroRNAs and Erythroid Growth, Proliferation, Differentiation and Apoptosis [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(4): 445-448.
[10]	LIU Su-rui, YANG Xiao-ya, GAO Yu-hua, et al. PRP Releasate Prepared with Calcium Gluconate and Calcium Chloride in Promotion of Migration and Adhesion of UcMScs [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(1): 28-31.
[11]	WU Jin-ju, GUO Qing, LIU Xin, et al. The Impact of Bortezomib and Idarubicin Therapy on Calreticulin Expression and Apoptosis of Acute Myeloid Leukmia Cells [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2019, 21(5): 502-505.
[12]	LI Juan, LUO Yi-qing, FANG Man, et al. The Influence of Platelets on Apoptosis of Lung Cancer Cells [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2019, 21(1): 20-23.
[13]	ZHENG WEI-wei, LV CHANG-kun, ZHANG WEN-jing. Mechanism of Triptolide Induced Apoptosis of Acute Myelogenous Leukemia Stem Cells [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2017, 19(6): 540-542.
[14]	Jia-jia, LIU Yu-sheng. Trichostatin A Combined with All-trans Retinoic Acid Induce Apoptosis in Human Ovarian Cancer Cell Line SKOV-3 SHENG [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2017, 19(4): 321-324.